Search results for "Neurochemical"

showing 10 items of 89 documents

NEUROCHEMICAL STUDIES WITH L-CYCLOSERINE, A CENTRAL DEPRESSANT AGENT.

1963

CerebellumCarboxy-LyasesThalamusCaudate nucleusPharmacologyBiochemistryAminobutyric acidCellular and Molecular Neurosciencechemistry.chemical_compoundMiceNeurochemicalThalamusMesencephalonCerebellummedicineAnimalsPyridoxal phosphateEnzyme InhibitorsTransaminasesCerebral CortexPharmacologyAminobutyratesResearchCycloserineBrainNeurochemistryElectrophysiologymedicine.anatomical_structurechemistryCerebral cortexCycloserinePyridoxal PhosphateCaudate Nucleusmedicine.drugBrain StemJournal of neurochemistry
researchProduct

Human brain mechanisms of pain perception and regulation in health and disease

2005

Context: The perception of pain due to an acute injury or in clinical pain states undergoes substantial processing at supraspinal levels. Supraspinal, brain mechanisms are increasingly recognized as playing a major role in the representation and modulation of pain experience. These neural mechanisms may then contribute to interindividual variations and disabilities associated with chronic pain conditions. Objective: To systematically review the literature regarding how activity in diverse brain regions creates and modulates the experience of acute and chronic pain states, emphasizing the contribution of various imaging techniques to emerging concepts. Data Sources: MEDLINE and PRE-MEDLINE s…

Diagnostic ImagingAfferent Pathwaysmedicine.diagnostic_testSensationChronic painBrainNociceptorsPainCognitionContext (language use)Sensory systemHuman brainElectroencephalographymedicine.diseasePain IntractableAnesthesiology and Pain MedicineNeurochemicalmedicine.anatomical_structuremedicineHumansPerceptionNeurochemistryNerve NetPsychologyNeuroscienceEuropean Journal of Pain
researchProduct

Neurobiological mechanisms of the reinstatement of drug-conditioned place preference.

2009

Drug addiction is a chronic disorder characterized by a high rate of relapse following detoxification. There are two main versions of the reinstatement model that are employed to study relapse to drug abuse; one based on the operant self-administration procedure, and the other on the classical conditioned place preference procedure. In the last seven years, the use of the latter version has become more widespread, and the results obtained complement those obtained in self-administration studies. It has been observed that the conditioned place preference induced by opioids, psychostimulants, nicotine, ethanol and other drugs of abuse can be extinguished and reinstated by drug priming or expo…

DrugSubstance-Related Disordersmedia_common.quotation_subjectSelf AdministrationDevelopmental psychologyNicotineNeurochemicalNeuropsychologymedicineSecondary PreventionAnimalsHumansmedia_commonBehavior AnimalGeneral NeuroscienceAddictionBrainCognitionmedicine.diseaseConditioned place preferenceSubstance abuseDisease Models AnimalConditioning OperantNeurology (clinical)PsychologyNeurosciencePriming (psychology)Stress Psychologicalmedicine.drugBrain research reviews
researchProduct

Structural effects and neurofunctional sequelae of developmental exposure to psychotherapeutic drugs: experimental and clinical aspects

2004

The advent of psychotherapeutic drugs has enabled management of mental illness and other neurological problems such as epilepsy in the general population, without requiring hospitalization. The success of these drugs in controlling symptoms has led to their widespread use in the vulnerable population of pregnant women as well, where the potential embryotoxicity of the drugs has to be weighed against the potential problems of the maternal neurological state. This review focuses on the developmental toxicity and neurotoxicity of five broad categories of widely available psychotherapeutic drugs: the neuroleptics, the antiepileptics, the antidepressants, the anxiolytics and mood stabilizers, an…

Drugmedicine.medical_specialtymedia_common.quotation_subjectPopulationDevelopmental toxicityserotonin-reuptake inhibitorsEpilepsyNeurochemicalmedicineAnimalsHumansprenatal phenytoin exposurePsychiatryeducationbeta-adrenergic-receptorsmedia_commonPharmacologyrat-brain developmentPsychotropic Drugseducation.field_of_studybusiness.industryMental DisordersNeurotoxicityBrainbeta-adrenergic-receptors; central-nervous-system; cerebellar granule cells; developing cerebral-cortex; fetal hydantoin syndrome; messenger-rna expression; prenatal phenytoin exposure; rat-brain development; serotonin-reuptake inhibitors; st-johns-wortmedicine.diseaseMental illnessdeveloping cerebral-cortexmessenger-rna expressionMoodcerebellar granule cellsMolecular Medicinecentral-nervous-systemPlant Preparationsst-johns-wortfetal hydantoin syndromebusiness
researchProduct

Impact of adolescent methamphetamine use on social cognition: A human-mice reverse translation study.

2021

Background: Methamphetamine dependence is associated with social cognition deficits that may underpin negative social outcomes. However, there are considerable inter-individual differences in social cognition within people with methamphetamine dependence, with age of onset of methamphetamine use being a potential contributing factor. Materials and methods: We conducted two sequential studies examining the link between age of onset of methamphetamine use (adolescence versus young adulthood) and performance in social cognition tests: (1) a human cross-sectional study in 95 participants with methamphetamine dependence varying in age of onset (38 with adolescent onset and 57 with adult onset) a…

Drugs of abuseAdultSocial CognitionAdolescentAmphetamine-Related DisordersToxicologyMethamphetamineMiceYoung AdultNeurochemicalSocial cognitionMedicineAnimalsHumansPharmacology (medical)Young adultPharmacologybusiness.industryAggressionAmphetaminesDopaminergicMethamphetamineAmfetaminesSocial relationAdolescènciaAdolescenceAggressionPsychiatry and Mental healthCross-Sectional StudiesDroguesAge of onsetmedicine.symptombusinessClinical psychologymedicine.drugDrug and alcohol dependence
researchProduct

Integration of Peripheral Adiposity Signals and Psychological Controls of Appetite

2007

Publisher Summary This chapter presents an overview of the major anatomical and neurochemical participants in brain reward circuitry. It also elaborates the evidence available to date that supports the hypothesis that energy regulatory signals can modulate food reward. Psychological modulation of feeding involves taste hedonics and preferences, and the rewarding aspects of food. The brain circuitries implicated in stimulus reward, and in the regulation of energy balance, have traditionally been considered as separate. However, more recently, accumulated evidence suggests that there is both anatomical and functional crosstalk between these sets of central nervous system (CNS) circuitry. Addi…

Efferentmedia_common.quotation_subjectLeptinCentral nervous systemAppetiteStimulus (physiology)Neurochemicalmedicine.anatomical_structureNegative feedbackmedicineBrain stimulation rewardPsychologyNeurosciencemedia_common
researchProduct

Electrophysiological and neurochemical studies following injection of mononucleotides and their derivatives.

1963

GuanineGuanineAdenine NucleotidesUracil NucleotidesAdenineBrainUracilElectroencephalographyNucleosidesCytosine NucleotidesBiochemistryGuanine NucleotidesCellular and Molecular Neurosciencechemistry.chemical_compoundCytosineNeurochemicalCytosine nucleotidechemistryBiochemistryLiverAdenine nucleotideUracilUracil nucleotideCytosineJournal of neurochemistry
researchProduct

Neurochemical substrates of the rewarding effects of MDMA: implications for the development of pharmacotherapies to MDMA dependence.

2015

In recent years, studies with animal models of reward, such as the intracranial self-stimulation, self-administration, and conditioned place preference paradigms, have increased our knowledge on the neurochemical substrates of the rewarding effects of 3,4-methylenedioxymetamphetamine (MDMA) in rodents. However, pharmacological and neuroimaging studies with human participants are scarce. Serotonin [5-hydroxytryptamine (5-HT)], dopamine (DA), endocannabinoids, and endogenous opiates are the main neurotransmitter systems involved in the rewarding effects of MDMA in rodents, but other neurotransmitters such as glutamate, acetylcholine, adenosine, and neurotensin are also involved. The most impo…

HallucinogenSubstance-Related DisordersN-Methyl-34-methylenedioxyamphetamineBiology03 medical and health sciences0302 clinical medicineNeurochemicalRewardNeurotransmitter receptorDopamineConditioning PsychologicalmedicineAnimalsHumansNeurotransmitter metabolismPharmacologyBrainMDMAConditioned place preference030227 psychiatryReceptors NeurotransmitterPsychiatry and Mental healthHallucinogensSerotoninNeurosciencepsychological phenomena and processes030217 neurology & neurosurgerymedicine.drugBehavioural pharmacology
researchProduct

Behavioural and neurochemical effects after repeated administration of N-ethylpentylone (ephylone) in mice

2022

N-ethyl-pentylone (NEP), also known as "ephylone" and N-ethylnorpentylone, has been identified as one of the most recent novel psychostimulants to emerge into the illicit drug market and it has been associated with some intoxications and even fatalities. However, little is known about the consequences of its repeated consumption as well as the role of the monoaminergic system in such consequences. Thus, the aim of our study was to investigate the neurochemical profile and the behavioural effects after both acute and repeated NEP exposure. Male OF1 mice were acutely (1, 3, 10 mg/kg, i.p.) or repeatedly (1, 3, 10 mg/kg, i.p., 5 days, twice/day) exposed to NEP, and anxiety-like behaviour, aggr…

HyperthermiaMaleDrugs of abusemedicine.medical_specialtymedicine.drug_classStimulantsStriatumButylaminesBiochemistryAnxiolyticCellular and Molecular NeuroscienceMiceNeurochemicalAggressivenessInternal medicineMonoaminergicmedicineAnimalsBenzodioxolesPrefrontal cortexBehavior Animalbusiness.industryfungiEstimulantsmedicine.diseaseEndocrinologySocial explorationCentral Nervous System StimulantsSerotoninDroguesAgressivitatbusiness
researchProduct

Neurochemical correlates of brain atrophy in fibromyalgia syndrome: a magnetic resonance spectroscopy and cortical thickness study

2020

(1) Background: Recently, a series of clinical neuroimaging studies on fibromyalgia (FM) have shown a reduction in cortical volume and abnormally high glutamate (Glu) and glutamate + glutamine (Glx) levels in regions associated with pain modulation. However, it remains unclear whether the volumetric decreases and increased Glu levels in FM are related each other. We hypothesized that higher Glu levels are related to decreases in cortical thickness (CT) and volume in FM patients. (2) Methods: Twelve females with FM and 12 matched healthy controls participated in a session of combined 3.0 Tesla structural magnetic resonance imaging (MRI) and single-voxel MR spectroscopy focused on the thalami…

In vivo magnetic resonance spectroscopymedicine.medical_specialtybrain MRIArticlelcsh:RC321-57103 medical and health sciences0302 clinical medicineNeurochemicalAtrophyNeuroimagingGyrusFibromyalgiaInternal medicinemedicinecortical thicknelcsh:Neurosciences. Biological psychiatry. Neuropsychiatry030304 developmental biology0303 health sciencesbusiness.industryGeneral NeuroscienceMR spectroscopyGlutamate receptorSettore MED/37 - Neuroradiologiacortical thicknessmedicine.diseaseSubcortical gray matterEndocrinologymedicine.anatomical_structurefibromyalgia; glutamate excitotoxicity; cortical thickness; brain MRI; chronic pain; MR spectroscopyMR spectroscopy; brain MRI; chronic pain; cortical thickness; fibromyalgia; glutamate excitotoxicity.fibromyalgiaSettore MED/36 - Diagnostica Per Immagini E Radioterapiabusinesschronic pain030217 neurology & neurosurgeryglutamate excitotoxicity
researchProduct